Home LiteratureArticle Details
PMID: 2580419 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Polyagglutinability due to loss of O-antigenic determinants in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.

Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology ·Vol. 93 ·No. 1 ·1985-02-00 ·Pages 7-13

Ojeniyi B, Baek L, Høiby N

Abstract

O-polyagglutinable P. aeruginosa are prevalent among chronically infected cystic fibrosis patients. In the present work, one O-group 3, one O-group 9 and one polyagglutinable 0-3/9 strain were analysed by use of both corresponding group specific antisera against the O-antigen and polyspecific antisera against all extractable antigens of the 3 strains. Quantitative immunoelectrophoresis and classical tube-agglutination methods were employed in the analysis. The results showed that the polyagglutinable strain contained 0.1% and the 0-9 strain 1%, respectively, of the O-antigen-containing LPS present in the 0-3 strain. It is discussed whether these differences represent a gradual antigenic adjustment to the defence mechanisms of the chronically infected patients.

MeSH Terms
Agglutination Antigens, Bacterial/analysis Cystic Fibrosis/microbiology Epitopes Humans Immunoelectrophoresis, Two-Dimensional Pseudomonas aeruginosa/immunology
Chemicals
Antigens, Bacterial Epitopes
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Ojeniyi B
Baek L
Høiby N
Article Info
Journal
Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology
Abbr.
Acta Pathol Microbiol Immunol Scand B
ISSN
0108-0180
Published
1985-02-00
Pages
7-13
Language
English
Region
Denmark
NLM ID
8206623
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com